Cargando…
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease
Polyglutamine (polyQ) tract expansion leads to proteotoxic misfolding and drives a family of nine diseases. We study spinal and bulbar muscular atrophy (SBMA), a progressive degenerative disorder of the neuromuscular system caused by the polyQ androgen receptor (AR). Using a knock-in mouse model of...
Autores principales: | Nath, Samir R., Lieberman, Matthew L., Yu, Zhigang, Marchioretti, Caterina, Jones, Samuel T., Danby, Emily C. E., Van Pelt, Kate M., Sorarù, Gianni, Robins, Diane M., Bates, Gillian P., Pennuto, Maria, Lieberman, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166004/ https://www.ncbi.nlm.nih.gov/pubmed/32306066 http://dx.doi.org/10.1007/s00401-020-02156-4 |
Ejemplares similares
-
Skeletal Muscle Pathogenesis in Polyglutamine Diseases
por: Marchioretti, Caterina, et al.
Publicado: (2022) -
Introduction to the Special Issue “Skeletal Muscle Atrophy: Mechanisms at a Cellular Level”
por: Zuccaro, Emanuela, et al.
Publicado: (2023) -
The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease
por: Nath, Samir R., et al.
Publicado: (2017) -
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism
por: Chivet, Mathilde, et al.
Publicado: (2020) -
Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes
por: Milioto, Carmelo, et al.
Publicado: (2017)